LWEL — Luckwel Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual income statement for Luckwel Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | — | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.451 | 0.537 | 0.623 | 0.536 | 0.435 |
| Operating Profit | -0.451 | -0.537 | -0.623 | -0.536 | -0.435 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
| Net Income After Taxes | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.029 | -0.029 | -0.005 | -0.004 | -0.003 |